These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 30950786)

  • 21. Vendor compliance with Ontario's tobacco point of sale legislation.
    Dubray JM; Schwartz RM; Garcia JM; Bondy SJ; Victor JC
    Can J Public Health; 2009; 100(2):109-12. PubMed ID: 19839285
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tobacco industry interference with tobacco control policies in Poland: legal aspects and industry practices.
    Balwicki Ł; Stokłosa M; Balwicka-Szczyrba M; Tomczak W
    Tob Control; 2016 Sep; 25(5):521-6. PubMed ID: 26418616
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Smokeless tobacco marketing and sales practices in Appalachian Ohio following federal regulations.
    Klein EG; Ferketich AK; Abdel-Rasoul M; Kwan MP; Kenda L; Wewers ME
    Nicotine Tob Res; 2012 Jul; 14(7):880-4. PubMed ID: 22318692
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Development of a computational modeling laboratory for examining tobacco control policies: Tobacco Town.
    Hammond RA; Combs TB; Mack-Crane A; Kasman M; Sorg A; Snider D; Luke DA
    Health Place; 2020 Jan; 61():102256. PubMed ID: 32329725
    [TBL] [Abstract][Full Text] [Related]  

  • 25. New Zealand tobacco control experts' views towards policies to reduce tobacco availability.
    Robertson L; Marsh L; Hoek J; McGee R
    N Z Med J; 2017 Jun; 130(1456):27-35. PubMed ID: 28571046
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effects of assurances of voluntary compliance on retail sales to minors in the United States: 2015-2016.
    Dai H; Catley D
    Prev Med; 2018 Jun; 111():410-414. PubMed ID: 29222044
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Retailer opinions about and compliance with family smoking prevention and tobacco control act point of sale provisions: a survey of tobacco retailers.
    Rose SW; Emery SL; Ennett S; Reyes HL; Scott JC; Ribisl KM
    BMC Public Health; 2015 Sep; 15():884. PubMed ID: 26362769
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Levels of support for the licensing of tobacco retailers in Australia: findings from the National Drug Strategy Household Survey 2004-2016.
    Baker J; Masood M; Rahman MA; Begg S
    BMC Public Health; 2020 May; 20(1):773. PubMed ID: 32448121
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Retailer licensing and tobacco display compliance: are some retailers more likely to flout regulations?
    Fry R; Burton S; Williams K; Walsberger S; Tang A; Chapman K; Egger S
    Tob Control; 2017 Mar; 26(2):181-187. PubMed ID: 27060100
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Assessing the Relationship between Retail Store Tobacco Advertising and Local Tobacco Control Policies: A Massachusetts Case Study.
    Usidame B; Miller EA; Cohen JE
    J Environ Public Health; 2019; 2019():1823636. PubMed ID: 31641360
    [TBL] [Abstract][Full Text] [Related]  

  • 31. How tobacco companies ensure prime placement of their advertising and products in stores: interviews with retailers about tobacco company incentive programmes.
    Feighery EC; Ribisl KM; Clark PI; Haladjian HH
    Tob Control; 2003 Jun; 12(2):184-8. PubMed ID: 12773729
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tobacco Control Policies in Brazil: a 30-year assessment.
    Portes LH; Machado CV; Turci SRB; Figueiredo VC; Cavalcante TM; Silva VLDCE
    Cien Saude Colet; 2018 Jun; 23(6):1837-1848. PubMed ID: 29972492
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Advancing the retail endgame: public perceptions of retail policy interventions.
    Whyte G; Gendall P; Hoek J
    Tob Control; 2014 Mar; 23(2):160-6. PubMed ID: 23842946
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Package size matters: tobacco packaging, retail merchandising and its influence on trial and impulse sales.
    Dewhirst T
    Tob Control; 2018 Sep; 27(5):600-602. PubMed ID: 29026000
    [No Abstract]   [Full Text] [Related]  

  • 35. What happens when the price of a tobacco retailer licence increases?
    Bowden JA; Dono J; John DL; Miller CL
    Tob Control; 2014 Mar; 23(2):178-80. PubMed ID: 23783508
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impact of flavoured tobacco restriction policies on flavoured product availability in Massachusetts.
    Kingsley M; Song G; Robertson J; Henley P; Ursprung WWS
    Tob Control; 2020 Mar; 29(2):175-182. PubMed ID: 30777880
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Using findings from a public opinion poll to build political support for tobacco control policy in Kenya.
    Maina WK; Kitonyo R; Ogwell AE
    Tob Control; 2013 Nov; 22(6):423-6. PubMed ID: 22628169
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Brand placement on price boards after tobacco display bans: a point-of-sale audit in Melbourne, Australia.
    Wakefield M; Zacher M; Scollo M; Durkin S
    Tob Control; 2012 Nov; 21(6):589-92. PubMed ID: 23002179
    [TBL] [Abstract][Full Text] [Related]  

  • 39. How has the introduction of point-of-sale legislation affected the presence and visibility of tobacco retailing in Scotland? A longitudinal study.
    Pearce J; Cherrie M; Best C; Eadie D; Stead M; Amos A; Currie D; Ozakinci G; MacGregor A; Haw S
    Tob Control; 2020 Mar; 29(2):168-174. PubMed ID: 30696782
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A comparison of three policy approaches for tobacco retailer reduction.
    Myers AE; Hall MG; Isgett LF; Ribisl KM
    Prev Med; 2015 May; 74():67-73. PubMed ID: 25689540
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.